Related by context. All words. (Click for frequent words.) 70 epithelial tumors 67 breast pancreatic 67 neoplastic 67 pancreatic lung 67 prostate pancreatic 67 p# mutations 67 TTR gene 67 ovarian breast 66 skeletal metastases 66 gastric cancers 66 neuroendocrine cancers 66 proto oncogene 65 premalignant 65 TGF alpha 65 WT1 65 lung adenocarcinomas 65 carcinomas 65 pancreatic prostate 65 pancreatic ovarian 65 NF kB pathway 65 apoptotic pathway 65 oncogenesis 65 myeloproliferative disorders 65 gastric adenocarcinoma 65 gastric carcinoma 64 solid tumors 64 epithelial tissues 64 pancreatic adenocarcinoma 64 lung carcinomas 64 pituitary adenomas 64 androgen receptor AR 64 epithelial cells lining 64 breast endometrial 64 vimentin 64 pancreatic colon 64 bladder cancers 64 leukemias lymphomas 64 FGFR2 64 lymphoma subtypes 64 precursor lesions 64 ovarian pancreatic 64 gastrointestinal cancers 64 breast carcinomas 64 malignancies 64 EpCAM 64 oncoprotein 64 Basal cell 64 myeloproliferative diseases 64 EGFR pathway 64 carcinoid 64 Wnt signaling pathway 64 epithelia 64 pulmonary metastases 64 chemokine receptors 64 FLT3 64 myelofibrosis polycythemia vera 63 colorectal gastric 63 ovarian lung 63 EGFr 63 mesotheliomas 63 breast cancer metastasis 63 lymphoid 63 malignant prostate 63 metastatic colorectal 63 biologic pathway 63 oncoproteins 63 MLL AF9 63 colorectal lung 63 EGFR inhibitors 63 cathepsins 63 cell adhesion molecule 63 adenocarcinomas 63 isotypes 63 Epstein Barr virus EBV 63 factor receptor EGFR 63 myelomas 63 astrocytomas 63 ADPKD 63 mtDNA mutations 63 miRs 63 metachronous 63 surface glycoprotein 63 HER2 receptor 63 oligodendrogliomas 63 prostate carcinoma 63 ovarian colon 63 NFκB 63 NKG2D 63 CD# molecule 63 hematopoietic cells 63 IGF IR 63 squamous cell carcinoma SCC 63 gastrointestinal stromal tumors GISTs 63 serine proteases 63 c MYC 63 SSc 63 serous ovarian cancer 63 neoplastic cells 62 PKCi 62 renal fibrosis 62 BRAF mutation 62 V#F mutation 62 signaling cascades 62 molecular biomarkers 62 lymphoid organs 62 glycosylated 62 oncogenes 62 ERBB2 62 anemias 62 CYT# potent vascular disrupting 62 JAK inhibitors 62 lobular carcinoma 62 inducible nitric oxide synthase 62 molecular abnormalities 62 VEGF receptor 62 lymphomas 62 aberrantly activated 62 gastric carcinomas 62 pancreatic cancers 62 GISTs 62 virulence genes 62 cancers 62 mesothelin 62 epithelial cell 62 hamartomas 62 KRAS oncogene 62 sPLA2 62 posttranslational modifications 62 neovasculature 62 Smad3 62 Mesothelin 62 ERK signaling 62 A3 adenosine receptor 62 EGFR protein 62 leukaemias 62 squamous cell 62 JAK2 mutation 62 renal cell carcinomas 62 hypermethylated 62 MUC1 62 HNSCC 62 EGFR HER2 62 hepatic stellate cells 62 myeloproliferative neoplasms 62 Treg cell 62 papillary renal cell carcinoma 62 proliferative disorders 62 prostate carcinomas 62 colorectal carcinoma 62 c myc 62 pancreatic gastric 62 somatostatin receptors 62 pancreatic endocrine 62 tumoral 62 LRP5 62 tumorigenicity 62 kidney urologic 62 miR #b [001] 61 basal cells 61 mutant p# 61 lung pancreatic 61 proteoglycan 61 GPNMB 61 malignant transformation 61 mitogen activated protein kinases 61 hCG beta 61 IGF 1R 61 MALT lymphoma 61 ovarian carcinoma 61 gastric pancreatic 61 tumor antigen 61 MMP# 61 neurofibromas 61 ductal carcinomas 61 SMAD4 61 IGFBP2 61 FGFR1 61 lymphoid tissue 61 neoplasias 61 CD# receptor 61 lymphangiogenesis 61 thyroid carcinomas 61 fibrotic disease 61 genomic alterations 61 hematologic malignancies 61 cisplatin resistant 61 eIF 4E 61 osteosarcomas 61 Fibroblast Growth Factor Receptor 61 proliferative diseases 61 HPVs 61 essential thrombocythemia 61 PGDH 61 hypermethylation 61 immunological diseases 61 neural tissues 61 premalignant lesions 61 monocytes macrophages 61 cell lymphomas 61 axillary lymph nodes 61 HER2 positive cancers 61 cytomegalovirus CMV 61 metastasis 61 TNFa 61 ERK1 2 61 Ras pathway 61 Leydig cell 61 neoplastic lesions 61 lymphoid tissues 61 STK# [002] 61 endocrine tumors 61 RRM1 61 tenascin 61 ADAM# 61 mesenchymal cell 61 colon pancreatic 61 p# MAPK 61 cervical carcinoma 61 HAAH 61 metastatic cancers 61 secreted protein 61 sarcomas 61 metastatic lymph nodes 61 protein tyrosine phosphatases 61 CD# antigen 61 potent inhibitors 61 GSTP1 61 lung adenocarcinoma 61 lymphoid tumors 61 neuroendocrine tumors 61 colorectal pancreatic 61 RAS pathway 61 activating mutations 61 fibrocytes 61 motor neuron degeneration 61 myeloid cells 61 oncogenic transformation 61 FGFs 60 carbohydrate antigens 60 cyclin E 60 MAGE A3 60 intestinal epithelium 60 DNA methyltransferases 60 activated lymphocytes 60 retinoic acid receptor 60 basal cell carcinoma BCC 60 herpesviruses 60 receptor CD# 60 EGF receptor 60 Notch1 60 invasive ductal 60 carcinoembryonic antigen 60 cervical breast 60 matrix metalloproteinases 60 M2 subunit 60 clonogenic 60 Epstein Barr Virus EBV 60 CCR9 60 colorectal adenocarcinoma 60 MAPK pathway 60 CCR7 60 syngeneic 60 neuroblastomas 60 genetic aberrations 60 carcinoid tumors 60 cMET 60 pro angiogenic 60 ABCB1 60 KRAS mutant 60 haematopoietic 60 trophoblast cells 60 mutational status 60 DLX5 60 activin 60 situ LCIS 60 gastrin 60 synovial cells 60 lymphoid cells 60 ErbB3 60 bronchial epithelial cells 60 endometrial cancers 60 atherosclerotic lesions 60 metastatic melanomas 60 CagA 60 breast ovarian 60 PDGFR 60 intestinal epithelial cells 60 IL #R 60 cell signaling pathways 60 chemokine receptor 60 nucleolin 60 miRNA genes 60 c MET 60 IL 1β 60 AAV2 60 MAP kinases 60 p#INK#a 60 idiopathic myelofibrosis 60 PARP inhibition 60 metastatic prostate 60 neoplastic diseases 60 K ras mutations 60 Pim kinases 60 immunomodulation 60 castration resistant 60 squamous cell carcinomas 60 epithelial tissue 60 opportunistic pathogens 60 downregulating 60 metastatic tumors 60 cell adhesion molecules 60 cytolytic 60 EGF receptors 60 ALK mutations 60 HbF 60 autoimmune diseases 60 tryptase 60 Raf MEK ERK 60 colony stimulating factors 60 receptors EGFR 60 carcinogenesis 60 neoplasms 60 neurite outgrowth 60 nasopharyngeal carcinoma 60 Gliomas 60 Symadex 60 MGUS 60 HER2 overexpression 60 miR #a [001] 60 xenograft models 60 histologic subtype 60 p# activation 60 tissue fibrosis 60 renal tumors 60 CTGF 60 neuropilin 60 Fas ligand 60 oncogenic 60 uPAR 60 intracellular pathways 60 Helicobacter 60 tyrosine kinases 60 prostate breast 60 heterologous 60 small molecule activators 60 metastatic neuroendocrine tumors 60 NKX#.# 60 galectins 60 epigenetic markers 60 engineered RAP peptides 60 osteoblast 60 myopathies 60 Epidermal Growth Factor 60 STAT3 60 ependymomas 60 tumor metastasis 60 leiomyoma 60 ERK pathway 60 EGFR mutations 60 Proxinium TM 60 CXCR4 60 missense mutations 60 histone modifications 60 ccRCC 60 sphingolipid 60 Activating mutations 60 commonly mutated genes 60 tumorigenesis 60 SPINK1 60 Glioblastomas 60 coagulation disorders 60 specific lectin receptors 60 alveolar epithelial cells 60 ovarian prostate 59 pancreatic islet 59 receptor subtype 59 metastatic bladder 59 hematologic disorders 59 Squamous cell 59 prognostic markers 59 prognostic indicator 59 lung epithelial cells 59 glioblastoma multiforme GBM 59 Dysregulation 59 transcriptional regulation 59 HER-2/neu 59 hedgehog pathway 59 anti angiogenic drugs 59 JAK2 enzyme 59 caveolin 1 59 EZH2 59 GRP# 59 lobular carcinomas 59 protein tyrosine phosphatase 1B 59 hyperplastic 59 neuroendocrine cells 59 immunodeficiency disorders 59 CanAg 59 therapeutically useful 59 abnormal p# 59 hepatocellular carcinoma HCC 59 signal transduction pathways 59 serine threonine 59 miR #a [002] 59 inhibitory receptor 59 malignant pancreatic 59 hormone gastrin 59 epigenetic mechanisms 59 bladder ovarian 59 mesenchymal cells 59 neoplasm 59 E#F# 59 TGF β 59 myeloid 59 RAS RAF MEK 59 Sezary syndrome 59 TLR8 59 malignant pheochromocytoma 59 Clusterin 59 GBM tumors 59 EGFR tyrosine kinase inhibitors 59 ductal breast cancer 59 PI3K Akt 59 PCA3 gene 59 hematological disorders 59 histone deacetylases 59 metastatic lesions 59 CXCR7 59 transgene expression 59 PC# cells 59 matrix metalloproteinases MMPs 59 mesothelial cells 59 pathophysiological effects 59 prostate adenocarcinoma 59 pilocytic astrocytomas 59 antiangiogenic drugs 59 malignant fibrous histiocytoma 59 Flt3 59 GATA3 59 p# INK4a 59 TMEM#B 59 humanized monoclonal antibody 59 lung colon 59 hepatocellular carcinoma 59 Gleevec resistant 59 hypoxia inducible factor 59 GPC3 59 Cyclin E 59 biologic pathways 59 Hedgehog pathway 59 myogenesis 59 malignant tumors 59 basophils 59 c myc gene 59 prostate epithelial cells 59 MEK inhibitors 59 mycosis fungoides 59 γδ T cells 59 invasive carcinoma 59 papillomas 59 demyelinating diseases 59 catenin 59 carcinoma HCC 59 depsipeptide 59 Lyn kinase 59 KIF6 gene 59 skin fibroblasts 59 hyperactivated 59 antisense inhibitors 59 chronic viral infections 59 tumor suppressor protein 59 immunoregulation 59 chitinase 59 PIK3CA 59 muscular dystrophies 59 synaptogenesis 59 peritoneal carcinomatosis 59 RNAi therapeutic targeting 59 Hashimoto thyroiditis 59 antiproliferative effects 59 RIP1 59 neuroblastoma tumors 59 protein tyrosine phosphatase 59 ectopic expression 59 hypereosinophilic syndrome 59 gastrointestinal stromal tumor 59 cryptococcosis 59 delta isoform 59 osteoclast 59 HER2 neu 59 myeloperoxidase 59 mouse xenograft models 59 papillomaviruses 59 colorectal prostate 59 lymphocytic 59 Rap1 59 cellular pathways 59 testicular cancers 59 Candida infection 59 tumor metastases 59 splice variants 59 MYCN amplification 59 Hedgehog signaling 59 interferon IFN 59 SOD1 gene 59 renal carcinoma 59 medulloblastoma 59 cirrhosis liver failure 59 seminomas 59 CD1d 59 keratinocyte 59 EGFR mutant 59 grade gliomas 59 Her2/neu 59 fusion proteins 59 serine threonine kinases 59 B7 H3 59 IL 1ß 59 EphA2 59 neural crest 59 DNA methylation patterns 59 elastase 59 Stat5 59 retroviral vectors 59 constitutively expressed 59 prostate cancer CaP 59 squamous cell cancer 59 glioblastoma tumor 59 VIPR2 59 oxidases 59 uveal melanoma 59 crystallin 59 motor neuron diseases 59 viral antigens 59 Wnt pathway 59 TGF ß1 59 bone metastasis 59 hepatocyte 59 Factor VEGF 59 interleukin IL -# 59 microvascular endothelial cells 59 pDCs 59 nonmelanoma skin cancers 59 Foxp3 59 tumor suppressor genes 59 Factor Receptor 59 tRNA synthetases 59 NF kappaB activation 59 degenerative neurological diseases 58 HER2/neu 58 S#A# [002] 58 cytotoxin 58 Cathepsin B 58 BMP4 58 TAp# 58 IDH1 mutations 58 UsiRNAs 58 hTERT 58 Trp p8 58 histologies 58 HEK# 58 selective inhibition 58 hematopoietic malignancies 58 fibrin deposition 58 neural cells 58 IgG4 58 sarcomatoid 58 lymphatic tissue 58 B7 H4 58 immune modulators 58 BRAF V#E 58 MDR1 58 Papillary 58 carcinoids 58 kinase gene 58 NFkB 58 Immunohistochemical staining 58 HepG2 cells 58 B Raf 58 Endometrial cancer 58 SATB1 58 Th# cells 58 TNFR1 58 intracellular signaling pathways 58 adenoviral 58 p# mutation 58 metalloproteinase 58 CD4 + T lymphocytes 58 metastases 58 mammary epithelial cells 58 methylated DNA 58 immunopathology 58 adhesion molecule 58 multiple myeloma MM 58 dimerization 58 histological subtype 58 XL# inhibits 58 nodal metastasis 58 atypical hyperplasia 58 autocrine 58 telomere dysfunction 58 squamous cell lung cancer 58 sortilin 58 eccrine 58 Chronic lymphocytic leukemia 58 pre malignant lesions 58 IGFBP 3 58 interleukins 58 humanized monoclonal antibodies 58 Th2 cytokines 58 neuropsychiatric diseases 58 PDGF receptor 58 grade cervical intraepithelial 58 TTR amyloidosis 58 Glioblastoma multiforme GBM 58 neuroendocrine 58 metalloprotease 58 vitamin D receptors 58 Nod1 58 cyclin dependent kinase 58 paragangliomas 58 mucosal immunity 58 gene rearrangements 58 papillary 58 constitutively active 58 metastatic gastric 58 osteoblastic 58 hematological malignancies 58 iNOS 58 situ CIS 58 Galectins 58 Akt1 58 serotonin 2C receptor 58 tumor xenografts 58 Li Fraumeni 58 Mesenchymal 58 pathogenic mechanisms 58 receptor tyrosine kinase 58 epithelioid 58 tumor suppressors 58 inflammatory bowel diseases 58 ovarian tumors 58 Barrett mucosa 58 telomerase inhibition 58 pancreatic neuroendocrine 58 nAChR 58 colon carcinoma 58 colorectal tumors 58 pheochromocytoma 58 endogenous ligands 58 glioma cells 58 gastrointestinal stromal tumors 58 Sertoli cell 58 esophageal cancers 58 nonsmall cell lung cancer 58 nutlin 3a 58 extracellular domain 58 serine protease 58 nasopharyngeal carcinoma NPC 58 hepatoma 58 anti apoptotic proteins 58 estrogen receptor 58 Kupffer cells 58 constitutively 58 methylation markers 58 upregulated 58 histone acetylation 58 malignant lymphomas 58 neovascularization 58 virotherapy 58 tumors 58 TLE3 58 Smac mimetics 58 #T# L1 58 synovial sarcoma 58 anticancer agents 58 AT1R 58 costimulatory 58 humanized antibody 58 virulence determinants 58 hepatocellular cancer 58 multinucleated 58 serotonin receptor 58 chronic eosinophilic leukemia 58 schwannomas 58 basal cell carcinomas 58 lysosomal 58 multiple sclerosis rheumatoid arthritis 58 alpha synuclein gene 58 cytokine receptor 58 Src kinase 58 chromosomal rearrangement 58 recurrent NSCLC 58 EGFRvIII 58 synovial tissue 58 HDACi 58 familial ALS 58 neuroligins 58 urothelial cancer 58 PPARg 58 thymidylate synthase TS 58 somatostatin 58 Epidermal Growth Factor Receptor 58 N. gonorrhoeae 58 mTOR inhibitors 58 allergic inflammation 58 MMP9 58 benign moles 58 miRNA expression 58 coding genes 58 beta defensins 58 PTHrP 58 familial pancreatic cancer 58 EGFR mutation 58 urothelial carcinoma 58 neuroendocrine carcinoma 58 effector cells 58 Upregulation 58 PTPN# 58 EphB4 58 thyroid hormone receptor 58 transmembrane receptor 58 IGF1R 58 mutant proteins 58 skeletal muscle weakness 58 leukocyte recruitment 58 Skp2 58 imatinib Gleevec 58 mammary cancers 58 membrane receptors 58 distant metastasis 58 preclinical xenograft models 58 cholangiocarcinoma 58 prostate ovarian 58 CEACAM1 58 P. gingivalis 58 hematological cancers 58 STAT4 58 pleural mesothelioma 58 protein kinase C 58 CB2 receptor 58 cytokines IL 58 prognostic marker 58 chromosome aberrations 58 lymphoid malignancies 58 somatic mutations 58 radiosensitivity 58 OGG1 58 tumor xenograft models 58 untreated celiac disease 58 mitochondrial disorders 58 endocrine therapies 58 FUS1 58 immunodeficiencies 58 CCL# 58 phosphate S1P 58 cysteine protease 58 TLR9 agonists 58 gene amplification 58 anti CD3 58 Helicobacter infection 58 Hurthle cell 58 TCF#L# 58 neuronal differentiation 58 GPx 58 stem cells CSCs 58 FOXO3a 58 HepDirect prodrug 58 lung fibrosis 58 glioblastoma tumors 58 β catenin 58 bone marrow stromal cells 58 tumor hypoxia 58 VEGF expression 58 chemosensitivity 58 metabolic enzymes 58 mRNA expression 58 orthotopic model 58 trophoblasts 58 FGFR3 58 liver colon rectal 58 tumor subtypes 58 benign neoplasms 58 colon lung 58 N cadherin 58 RANK ligand 58 sodium thiosulfate STS 58 CD#L 58 medulloblastomas 58 N Myc 58 molecularly targeted 58 peptide antigens 58 telomerase inhibitor 58 meningiomas 57 myofibroblasts 57 glioblastoma cells 57 neuro endocrine 57 potent inducer 57 differentiated thyroid 57 recurrent glioblastoma multiforme 57 C EBP alpha 57 acid phosphatase PAP 57 Aurora kinase 57 deacetylation 57 cardiomyocyte 57 GBMs 57 polycystin 57 autophagic 57 androgen dependent 57 isoenzyme 57 MCF7 57 PHD2 57 activated microglia 57 fallopian tube cancers 57 SIRT1 gene 57 Wnt beta catenin 57 prostate lung 57 anti angiogenic agents 57 microglial 57 thymic carcinoma 57 penile cancers 57 mesothelium 57 liver metastases 57 neuroinflammation 57 carcinoembryonic antigen CEA 57 nonmelanoma 57 druggable targets 57 CD# expressing 57 TrkA 57 overexpressed 57 epithelial markers 57 proinflammatory cytokines 57 AGTR1 57 leukaemic stem cells 57 epigenetic modification 57 lymphomas leukemias 57 hCG Beta 57 aneuploidies 57 chronic periodontitis 57 cyclic AMP cAMP 57 glial tumors 57 ERCC1 57 MMP inhibitors 57 immunocompetent 57 MMP2 57 Peutz Jeghers syndrome 57 dermatophytes 57 thioredoxin 57 gamma globin gene 57 transgenic rats 57 tyrosine kinase inhibitors 57 transgenic mouse model 57 Genetic variants 57 induce apoptosis 57 pain syndromes 57 induce pluripotency 57 hedgehog signaling 57 receptor gamma 57 telomerase reverse transcriptase 57 T#I [002] 57 mediated autoimmune diseases 57 adipogenic 57 E cadherin expression 57 HER2 ErbB2 57 basal cell skin 57 estrogen receptor ER 57 selectively inhibited 57 breast cancer subtypes 57 CTNNB1 57 PLK1 57 JUVISTA R Human 57 alpha synuclein protein 57 beta1 integrin 57 Neuropeptide Y 57 MUC1 protein 57 cardiac myocytes 57 EBV infection 57 serum antibodies 57 Chronic inflammation 57 survivin 57 acinar 57 Leukemias 57 leukotriene pathway 57 IgG1 antibody 57 NPHP 57 RANKL 57 CP CPPS 57 inhibit metastasis 57 HLA DRB1 57 Wnts 57 antibody mediated 57 superantigens 57 methylation patterns 57 metaplasia 57 hepatocellular carcinomas 57 secondary hyperparathyroidism 57 stem cell pluripotency 57 histologic subtypes 57 node metastases 57 TGF b 57 MetAP2 57 CXCR4 receptor 57 carcinoma 57 cell malignancies 57 Insegia 57 evolutionarily conserved 57 murine model 57 plasma kallikrein 57 cell motility 57 pDC 57 squamous 57 IDH mutations 57 basal cell nevus syndrome 57 JNK pathway 57 Metastatic 57 factor PlGF 57 deacetylase inhibitors 57 HIF 1alpha 57 bone marrow lymph nodes 57 huC# DM4 57 VEGFR1 57 glycolipids 57 MDSCs 57 multidrug resistance 57 systemic inflammation 57 Glucocorticoids 57 p#NTR 57 Sjögren syndrome 57 downregulated 57 ADAMTS# 57 clade B 57 primary hyperparathyroidism 57 MAP kinase 57 pathogenetic 57 virulence factors 57 pediatric acute lymphoblastic 57 pAkt 57 cyclooxygenase 2 57 endothelial cell 57 upregulating 57 soluble tumor necrosis 57 p# mitogen activated 57 Hepatocellular Carcinoma HCC 57 CD#c 57 microRNA miR 57 HLA DR 57 molecular subtypes 57 autoantigens 57 follicular thyroid cancer 57 Mutational 57 Smac mimetic 57 cyclin dependent kinase inhibitor 57 Eg5 57 protein misfolding diseases 57 UVB induced 57 metastatic lung cancer 57 ENMD # 57 Endometrial 57 interferon pathway 57 diseases fat malabsorption 57 squamous cell cancers 57 etiologic agent 57 USP# 57 mucinous 57 breast carcinoma 57 ENaC 57 outer membrane proteins 57 epithelial ovarian 57 neural progenitor cells 57 trans retinoic acid 57 vascular endothelial cells 57 lentiviral vectors 57 cardiac fibroblasts 57 radiosensitive 57 melanocyte 57 orally bioavailable mimics 57 phosphorylate 57 COX2 57 leiomyosarcoma 57 intestinal polyps 57 histological subtypes 57 IL 1beta 57 kinase pathway 57 lymphoproliferative disorders 57 transcriptional repressor 57 HER2 HER2 57 basal cell 57 4E BP1 57 ErbB 57 secreted proteins 57 leukemia myeloma 57 selective antagonists 57 kallikrein 57 immunohistochemical staining 57 innate immune responses 57 genetic determinants 57 FGFR 57 cytoprotective 57 oropharyngeal cancer